Vitamin K for Your Newborn: What Parents Should Know

Why newborns need vitamin K

Vitamin K is a nutrient the body needs to make proteins that help blood clot normally. Without enough vitamin K, bleeding can start and may be difficult to stop.

Babies are born with very small stores of vitamin K for several reasons:

• Very little vitamin K passes from mother to baby during pregnancy.
• Breast milk has many important benefits, but it naturally contains relatively little vitamin K.
• A newborn's intestines do not yet have the bacteria that later contribute to vitamin K production.

Because of this, newborns naturally begin life with low vitamin K levels.

Usually this causes no problem. But without enough vitamin K, a baby can develop a serious condition called vitamin K deficiency bleeding, or VKDB.

What is vitamin K deficiency bleeding?

VKDB is bleeding caused by insufficient vitamin K.

Bleeding may be relatively minor, such as bruising or oozing from the umbilical cord, or it can occur internally where parents cannot see it.

In the most serious cases, bleeding can occur inside the brain.

Doctors divide VKDB into three types based on when it occurs:

• Early VKDB: During the first 24 hours after birth. This occurs mainly in babies whose mothers took certain medications during pregnancy that interfere with vitamin K.
• Classic VKDB: Usually between 2 days and 1 week of age.
• Late VKDB: From about 1 week through 6 months of age, most commonly between 2 and 8 weeks.

Late VKDB is particularly concerning because 30% to 60% of affected babies have bleeding inside the brain.

It occurs most often in exclusively breastfed babies who received no vitamin K or inadequate vitamin K prophylaxis.

One of the difficult things about VKDB is that a baby may appear completely healthy beforehand. Serious bleeding is often not preceded by obvious warning signs.

Are there warning signs of VKDB?

How well does the vitamin K shot work?

A single injection of vitamin K into the muscle shortly after birth is the most effective way to prevent VKDB.

The American Academy of Pediatrics has recommended vitamin K prophylaxis for newborns since 1961 and continues to recommend intramuscular vitamin K for newborn infants.

For most newborns weighing more than 1,500 grams, the recommended dose is 1 milligram given into the muscle within the first 6 hours after birth.

Very small premature infants receive a lower dose based on their weight.

The protection is substantial.

According to the Centers for Disease Control and Prevention, babies who do not receive the vitamin K shot at birth are about 81 times more likely to develop late VKDB than babies who receive it.

The injection provides a dependable store of vitamin K during the months when babies are most vulnerable.

Addressing common parental concerns

It is completely reasonable to have questions about anything given to your newborn.

These are some of the concerns parents commonly ask about.

“Does the shot hurt my baby?”

The injection causes brief discomfort, similar to other injections.

Parents can often hold, breastfeed, or provide skin-to-skin contact around the time of the injection to help comfort their baby.

The discomfort is brief, while the protection lasts through the period when babies are most vulnerable to vitamin K deficiency bleeding.

“Is vitamin K linked to childhood cancer?”

Current evidence does not support a link between the newborn vitamin K injection and childhood cancer.

This concern arose after a study published in 1992 reported a possible association between intramuscular vitamin K and childhood cancer.

That finding prompted additional research involving much larger numbers of children.

Subsequent studies did not confirm an increased risk of leukemia or other childhood cancers from newborn vitamin K prophylaxis.

“What exactly is in the vitamin K shot?”

Vitamin K is a vitamin, not a vaccine.

The active ingredient is phytonadione, or vitamin K1.

Vitamin K1 is the naturally occurring form of vitamin K also found in foods such as leafy green vegetables.

The injection also contains other ingredients that allow the vitamin to remain stable and be given safely.

Those inactive ingredients vary by manufacturer, so parents who want to know exactly which formulation their baby will receive can ask their hospital or birth team.

“What about preservatives such as benzyl alcohol?”

Some injectable vitamin K formulations contain benzyl alcohol, while other formulations are available without it.

The American Academy of Pediatrics notes that there is no evidence that the small amount of benzyl alcohol used in routine vitamin K prophylaxis has been associated with toxicity.

However, medication labeling recommends using a benzyl-alcohol-free formulation in newborns and infants when one is available.

If avoiding benzyl alcohol is important to you, ask your birth hospital which formulation it uses.

“Does the vitamin K shot contain mercury?”

The current U.S. neonatal vitamin K formulations reviewed for this article do not list thimerosal, ethylmercury, or another mercury-containing ingredient.

Because manufacturers and formulations can change, parents who want to verify this can ask which vitamin K product their birth hospital uses and review that product's current ingredient list.

“What about aluminum?”

Some injectable vitamin K formulations specify a very small upper limit for trace aluminum.

Aluminum is not the active ingredient in the vitamin K shot. Trace amounts can enter injectable medications during manufacturing.

For example, one current U.S. neonatal vitamin K product is labeled as containing no more than 500 micrograms of aluminum per liter.

The newborn dose from that product is 0.5 mL, which corresponds to no more than approximately 0.25 micrograms of aluminum in the entire dose.

Different products may have different trace-aluminum limits.

Warnings about aluminum toxicity from injectable medications are primarily concerned with repeated or prolonged parenteral exposure, particularly in premature infants or patients with impaired kidney function who may receive multiple aluminum-containing intravenous medications or prolonged parenteral nutrition.

That situation is very different from receiving a single intramuscular vitamin K injection at birth.

Parents who are concerned about aluminum exposure can ask their birth hospital which formulation it uses and review that product's prescribing information.

“Is the dose too high for a newborn?”

The dose is intentional.

Newborns begin life with very small vitamin K stores and remain vulnerable for months while their own vitamin K supply develops.

For newborns weighing more than 1,500 grams, the American Academy of Pediatrics recommends a standard 1-milligram intramuscular dose.

Very small premature infants receive a smaller dose based on weight.

The goal is to provide a reliable reserve during the period when a baby cannot yet maintain adequate vitamin K levels independently.

“We want a natural birth with as few interventions as possible.”

That is an understandable goal.

It helps to know that having very little vitamin K at birth is itself a natural part of newborn physiology.

Unfortunately, that natural state also creates a small but potentially serious risk of bleeding.

The injection provides vitamin K1 during the period when a newborn cannot yet reliably obtain or produce enough on their own.

“Can breastfeeding provide enough vitamin K?”

Breastfeeding has many important benefits and remains strongly recommended.

However, breast milk naturally contains relatively small amounts of vitamin K.

Breastfeeding alone does not provide enough vitamin K to reliably prevent VKDB during early infancy.

This is not a problem with breastfeeding. It is simply one of the normal differences between newborn nutrition and adult nutrition.

Babies who receive the recommended vitamin K injection can breastfeed normally and do not need additional routine vitamin K supplementation for VKDB prevention.

“Can I take extra vitamin K during pregnancy instead?”

Routine maternal vitamin K intake or supplementation during pregnancy does not replace newborn vitamin K prophylaxis.

Only small amounts of vitamin K cross the placenta from mother to baby, which is one reason newborns begin life with such low stores.

The recommended newborn injection provides protection directly to the baby during the vulnerable first months.

What about oral vitamin K instead of the shot?

Some parents ask whether vitamin K can be given by mouth rather than by injection.

Oral vitamin K can reduce the risk of some forms of VKDB, and repeated oral regimens are used in some countries.

However, oral vitamin K does not protect as reliably against late VKDB as the intramuscular injection.

There are several reasons:

• Oral vitamin K must be given repeatedly rather than as a single dose.
• Absorption from the intestine can vary.
• Missed doses reduce protection.
• Babies with unrecognized liver, bile-flow, or absorption problems may not absorb oral vitamin K adequately.
• Cases of late VKDB have occurred even in countries using repeated oral prophylaxis schedules.

For these reasons, the American Academy of Pediatrics recommends the intramuscular vitamin K injection and does not consider oral vitamin K an equivalent substitute for preventing VKDB.

In the United States, there is also no oral vitamin K product specifically approved by the FDA for routine newborn VKDB prophylaxis.

If you are considering declining the injection, discuss this with your baby's pediatrician before birth whenever possible.

Your pediatrician can explain the risks, answer your questions, and discuss what options are actually available where your baby will be born.

Why the decision matters

The vitamin K decision is somewhat different from many other newborn preventive decisions because VKDB can occur in an infant who appeared completely healthy beforehand.

There may be no warning bleed before a serious event.

When late VKDB occurs, bleeding inside the brain is common and can cause permanent neurologic injury or death.

Fortunately, vitamin K deficiency bleeding is largely preventable.

That is why the American Academy of Pediatrics and other newborn-care organizations recommend vitamin K prophylaxis for newborns.

The bottom line

• Newborns naturally begin life with very low vitamin K stores.
• Low vitamin K can rarely cause serious or life-threatening bleeding called VKDB.
• A single intramuscular vitamin K injection shortly after birth is the most reliable way to prevent VKDB.
• Babies who do not receive the shot have a dramatically higher risk of late VKDB.
• Current evidence does not support a link between newborn vitamin K injections and childhood cancer.
• Current U.S. neonatal formulations reviewed for this article do not list thimerosal or another mercury-containing ingredient.
• Some formulations may contain extremely small amounts of trace aluminum, which is very different from the prolonged intravenous exposure associated with aluminum toxicity concerns.
• Oral vitamin K is less reliable than the injection and is not considered an equivalent substitute by the American Academy of Pediatrics.
• Breastfeeding remains strongly recommended, but breast milk alone does not provide enough vitamin K to prevent VKDB.

Questions about newborn care are reasonable, and parents deserve clear answers.